Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
UMK-121
print preview
bookmark
share with colleague
General Information
Company
Proteonomix Ltd.
Description
Combination of 2 undisclosed, approved drugs used to mobilize stem cells from bone marrow
Molecular Target
Mechanism of Action
Latest Stage of Development
Phase I
Indication
Liver disease
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information